Cardanol: toxicogenetic assessment and its effects when combined with cyclophosphamide

Abstract Cardanol is an effective antioxidant and is a compound with antimutagenic and antitumoral activity. Here, we evaluated the genotoxic and mutagenic potential of saturated side chain cardanol and its effects in combination with cyclophosphamide in preventing DNA damage, apoptosis, and immunomodulation. Swiss mice were treated with cardanol (2.5, 5 and 10 mg/kg) alone or in combination with cyclophosphamide (100 mg/kg). The results showed that cardanol is an effective chemopreventive compound, with damage reduction percentages that ranged from 18.9 to 31.76% in the comet assay and from 45 to 97% in the micronucleus assay. Moreover, cardanol has the ability to reduce the frequency of apoptosis induced by cyclophosphamide. The compound did not show immunomodulatory activity. A final interpretation of the data showed that, despite its chemoprotective capacity, cardanol has a tendency to induce DNA damage. Hence, caution is needed if this compound is used as a chemopreventive agent. Also, this compound is likely not suitable as an adjuvant in chemotherapy treatments that use cyclophosphamide.

Bibliographic Details

Main Authors:	Schneider,Beatriz Ursinos Catelan, Meza,Alisson, Beatriz,Adilson, Pesarini,João Renato, Carvalho,Pamela Castilho de, Mauro,Mariana de Oliveira, Karaziack,Caroline Bilhar, Cunha-Laura,Andréa Luiza, Monreal,Antônio Carlos Duenhas, Matuo,Renata, Lima,Dênis Pires de, Oliveira,Rodrigo Juliano
Format:	Digital revista
Language:	English
Published:	Sociedade Brasileira de Genética 2016
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572016000200279
Tags:	Add Tag No Tags, Be the first to tag this record!